Significant Shareholders

You have clicked on a link that will take you to a third-party website that Alliance Pharmaceuticals plc group (“Alliance”) is not responsible for.

Please read the following disclaimer and click “I agree” to proceed to the third-party website.

By clicking to continue you agree that:You are leaving Alliance`s website.

Alliance:

Is not responsible for the content or accuracy of the third-party website nor endorse or guarantee any services or information they may offer.
Does not represent either the third-party website or you (the visitor) if you enter into an agreement or transaction.
Privacy and security policies do not apply to third-party websites.

Shares in Issue: 530,412,678 1p Ordinary Shares

Last updated: 19th November 2021

Significant Shareholders	Amount	% Holding
Fidelity Management & Research	53,600,055	9.98
Slater Investment	48,906,041	9.10
Kempen Capital Management	39,173,000	7.29
BlackRock Investment Management	28,391,678	5.29
Investec Group	23,674,295	4.41
Polar Capital	20,040,270	3.73
Rathbone plc	19,568,454	3.64
John Dawson	17,558,284	3.27

Shareholdings of Directors & their families	Amount	% Holding
Peter Butterfield	442,104	0.08
David Cook	234,129	0.04
Andrew Franklin	128,384	0.02
Richard Jones	15,000	0.00